Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
2.880
-0.100 (-3.36%)
At close: Aug 10, 2026, 4:00 PM EDT
2.910
+0.030 (1.04%)
After-hours: Aug 10, 2026, 7:57 PM EDT
Virax Biolabs Group Employees
Virax Biolabs Group had 26 employees as of March 31, 2026. The number of employees increased by 7 or 36.84% compared to the previous year.
Employees
26
Change (1Y)
7
Growth (1Y)
36.84%
Revenue / Employee
$478
Profits / Employee
-$193,221
Market Cap
2.30M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 26 | 7 | 36.84% |
| Mar 31, 2025 | 19 | 2 | 11.76% |
| Mar 31, 2024 | 17 | 6 | 54.55% |
| Mar 31, 2023 | 11 | 6 | 120.00% |
| Mar 31, 2022 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Calidi Biotherapeutics | 29 |
| Moleculin Biotech | 17 |
| Azitra | 13 |
| Genprex | 13 |
| Decoy Therapeutics | 11 |
| Artelo Biosciences | 7 |
| GRI Bio | 4 |
| CDT Equity | 4 |
VRAX News
- 17 days ago - Virax Biolabs files to sell 1.68M ordinary shares for holders - TheFly
- 25 days ago - Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement - PRNewsWire
- 4 weeks ago - Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds - PRNewsWire
- 4 weeks ago - Virax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds - PRNewsWire
- 4 weeks ago - Why this biotech stock more than tripled on Thursday - Invezz
- 4 weeks ago - Why Is Penny Stock Virax Biolabs (VRAX) Up Today? - TipRanks
- 4 weeks ago - Virax Biolabs signs multi-country commercial agreement with Fosun Diagnostics - TheFly
- 4 weeks ago - Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics - PRNewsWire